SALT LAKE CITY – Pyrexar Medical, world leaders in thermal therapy / hyperthermia cancer treatment systems announces the company’s move to a new corporate headquarters. After five months operating in the former BSD Medical building, Pyrexar Medical has moved into its new corporate office and manufacturing facility. The new facility increases the headquarters footprint by fifty percent. The move allows for a revamped manufacturing and QC process, with additional space for research and development.
Part of the rebuilding of the hyperthermia brand includes shedding off outdated manual manufacturing processes and transferring information management to the cloud. Acquisition the of latest in ERP/MRP, CRM and CAD software, increases data stability, and brings company wide transparency from lead acquisition, thru the sales process, to delivery and service. These investments not only increase productivity but also are aimed at keeping an eye on the bottom line.
“Creating a new workflow has been an enjoyable project for the team.” Says Mark Falkowski. “We have already reduced manufacturing time by two thirds and expect to see a significant cost reduction and immediate return on investment.”
The new building, located minutes from Salt Lake International airport, creates gateway access to the company’s worldwide distribution network; with offices in China, Japan, Taiwan, Germany, UK, South Korea, Spain, UAE, Iran, and Turkey.
ABOUT PYREXAR MEDICAL:
Pyrexar Medical is a pioneer and worldwide market leader in the development and manufacture of innovative and highly effective thermal therapy/hyperthermia treatment systems with established distribution and support networks around the world. PYREXAR HyperThermia (PYREXAR HT) treatments, proven in multiple clinical trials over the last 30 years, increase the effective dose of ionizing radiation in solid tumors up to 3X without increasing toxicity to healthy tissues. To find out more about Pyrexar Medical products, visit our webpage www.pyrexar.com.
News Provided By: Submit Press Release 123
